,
, Focused Update of ESC Guidelines for the Management of Atrial Fibrillation, Eur Heart J, vol.33, issue.21, pp.2719-2766, 2012.
Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited, Stroke, vol.44, issue.11, pp.3103-3111, 2013. ,
guidelines for the management of atrial fibrillation, developed in collaboration with EACTS, Eur Heart J, vol.37, issue.38, pp.2893-962, 2016. ,
Efficacy of ? blockers in patients with heart failure plus atrial fibrillation: an individualpatient data meta-analysis. The Lancet, vol.384, pp.2235-2278, 2014. ,
,
, European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. EP Eur, vol.15, pp.625-51, 2013.
,
, Dabigatran versus Warfarin in Patients with Atrial Fibrillation, N Engl J Med, vol.361, issue.12, pp.1139-51, 2009.
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, N Engl J Med, vol.365, issue.10, pp.883-91, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01038111
Apixaban versus Warfarin in Patients with Atrial Fibrillation, N Engl J Med, vol.365, issue.11, pp.981-92, 2011. ,
,
, Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48, Eur Heart J Acute Cardiovasc Care, 2018.
Nonvitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis, Int J Cardiol, vol.268, pp.143-151, 2018. ,
Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients, Heart, vol.100, issue.5, pp.396-405, 2014. ,
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials, J Am Geriatr Soc, vol.62, issue.5, pp.857-64, 2014. ,
Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD, J Am Soc Nephrol, vol.25, issue.3, pp.431-473, 2014. ,
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study, vol.33, pp.55-64, 2016. ,
Risk of Bleeding With Dabigatran in Atrial Fibrillation, JAMA Intern Med, vol.175, issue.1, pp.18-24, 2015. ,
Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing, Cardiology, vol.140, pp.126-158, 2018. ,
, L'Assurance Maladie. Nouveaux anti-coagulants oraux : une étude de l'Assurance Maladie souligne la dynamique forte de ces nouveaux médicaments et la nécessité d'une vigilance accrue dans leur utilisation
, , 2013.
,
Vécu des patients en fibrillation auriculaire sous antocoagulants oraux ,
New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs, Thromb Haemost, vol.104, issue.6, pp.1099-105, 2010. ,
Meta-Analysis of the Safety and Efficacy of the Oral Anticoagulant Agents (Apixaban, Rivaroxaban, Dabigatran) in Patients With Acute Coronary Syndrome, Am J Cardiol, vol.121, issue.3, pp.301-308, 2018. ,
, nouveaux anticoagulants oraux et risques associés, 2016.
Realworld comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients, Curr Med Res Opin, vol.30, issue.7, pp.1317-1342, 2014. ,
,
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study, BMJ Open, vol.3, issue.5, 2013. ,
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation, The Cochrane Library ,
A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants, Int J Cardiol, 2018. ,
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, issue.8, pp.954-62, 2017. ,
French health insurance databases: What interest for medical research, Rev Med Interne, vol.36, issue.6, pp.411-418, 2015. ,
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation, J Thromb Haemost JTH, vol.16, issue.5, pp.833-874, 2018. ,
Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation, Curr Med Res Opin, vol.33, issue.6, 2017. ,
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation, J Am Heart Assoc, vol.5, issue.2, 2016. ,